BLFS
BioLife Solutions, Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$29.09-0.21%
Price as of Jul 20, 2026
BLFS profitability
BioLife Solutions, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 63.9%
- EBITDA margin
- -7.5%
- EBIT margin
- -10.9%
- Net margin
- -10.5%
- Free cash flow margin
- -1.8%
Returns
- Return on equity
- -2.8%
- Return on assets
- -2.6%
- Return on invested capital
- -2.8%
- Asset turnover
- 0.25x
Cash efficiency
- Cash from operations
- $17.9M
- Cash per share
- $1.66
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.